ESR1 and breast cancer: As shown in Supplementary Fig. S1g,h, positive associations were found between low LLGL2 mRNA expression and longer DFS and OS in ERα-positive breast cancer patients receiving adjuvant tamoxifen therapy (P = 0.016 and P = 0.018, respectively).